Pluristem wins approval to test placenta cell-based therapy in Israel

10/4/2013 | Pharmaceutical Business Review Online

Pluristem Therapeutics obtained clearance from the Israeli Ministry of Health to initiate a midstage trial of its PLacental eXpanded cells in patients with intermittent claudication. The trial in Israel will follow the same protocol used by Pluristem in its U.S. study, which involved around 150 patients.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Chief Medical Officer
VANDERBILT HEALTH AFFILIATE NETWORK
Nashville, TN
Commercial Health Insurance Strategist__Job #52-14
American Academy of Family Physicians
Leawood, KS
Manager of Payer Relations
Pharmacy Quality Solutions, Inc.
Raleigh/Durham, NC